Daily Market Reports | Jul 30 2025
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ADT BGL BSL CYL DYL FMG GGP HLO LYC MYX NST OBM PRU SEK TLC VAU (2) VYS
ADT ADRIATIC METALS PLC
Gold & Silver - Overnight Price: $5.80
Canaccord Genuity rates ((ADT)) as Hold (3) -
Adriatic’s mined ore in the March quarter fell short of Canaccord Genuity's forecast and was caused by limited access to the tailings storage facility. This resulted in a miss to the broker's AgEq production forecast.
Grades and recoveries were lower, and the broker believes higher spend on people vs mining is not an ideal situation. Cash at the end of the quarter was US$59m vs US$73m estimated by the broker.
FY25 production and mined ore guidance were lowered but the broker's forecasts were already below or on the low end.
Hold. Target price $6.00.
This report was published on July 28, 2025.
Target price is $6.00 Current Price is $5.80 Difference: $0.2
If ADT meets the Canaccord Genuity target it will return approximately 3% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 27.83 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.84.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 68.04 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.52.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BGL BELLEVUE GOLD LIMITED
Gold & Silver - Overnight Price: $0.85
Moelis rates ((BGL)) as Hold (3) -
Bellevue Gold announced its June quarter report with gold production of 287kt, which was below Moelis's forecast of 300kt. Cash and gold on hand came in at $152m, below the broker's $177m estimate, with free cash flow of $67m also falling short of expectations at $81m.
The analysts can see the upside potential for the share price when compared to the valuation of $1.05 but remain cautious due to the lack of guidance for FY2 (likely to be provided at the August earnings report) creating significant uncertainty around the year ahead.
Moelis lowers its FY25 earnings (EBITDA) forecast by -7% due to slightly higher assumed capex.
No change to Hold rating. Target unchanged at $1.05.
This report was published on July 28, 2025.
Target price is $1.05 Current Price is $0.85 Difference: $0.2
If BGL meets the Moelis target it will return approximately 24% (excluding dividends, fees and charges).
Current consensus price target is $1.18, suggesting upside of 40.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 36.96.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 4.4, implying annual growth of -32.5%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 19.2.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 11.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.66.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 10.7, implying annual growth of 143.2%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 7.9.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BSL BLUESCOPE STEEL LIMITED
Steel & Scrap - Overnight Price: $24.36
Jarden rates ((BSL)) as Downgrade to Neutral from Overweight (3) -
Jarden downgrades BlueScope Steel to Neutral from Overweight due to the share price outperformance and risk to FY26 earnings.
The analyst anticipates BlueScope will achieve slightly better 2H25 earnings before interest and tax, with US spreads at US$405/t against guidance of US$340/t, but upside risks could be constrained by economic uncertainty affecting demand and tariff impacts.
The company retains a strong balance sheet with estimated net cash of $56m and net debt targets of $400m–$800m.
Target price slips to $25 from $25.30.
This report was published on July 28, 2025.
Target price is $25.00 Current Price is $24.36 Difference: $0.64
If BSL meets the Jarden target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $27.04, suggesting upside of 11.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 60.00 cents and EPS of 105.70 cents.
At the last closing share price the estimated dividend yield is 2.46%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.05.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 101.8, implying annual growth of -43.4%.
Current consensus DPS estimate is 60.0, implying a prospective dividend yield of 2.5%.
Current consensus EPS estimate suggests the PER is 23.9.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 60.00 cents and EPS of 171.20 cents.
At the last closing share price the estimated dividend yield is 2.46%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 211.1, implying annual growth of 107.4%.
Current consensus DPS estimate is 60.0, implying a prospective dividend yield of 2.5%.
Current consensus EPS estimate suggests the PER is 11.5.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE